Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
The purpose of this study is to evaluate the effectiveness and safety of 2.5, 5 and 10 mg doses of mifepristone against a placebo in women with laparoscopic diagnostic of endometriosis. The hypothesis of the study is that the 5 mg mifepristone dose is safe and effective and should be used in future studies on medical treatment of endometriosis.
Epistemonikos ID: 149b6818068d483c46b364f2736d3cd5253c925e
First added on: Nov 24, 2021